Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomized, placebo-controlled trial. This evidence concerns the gene NR1H4 and metabolic dysfunction-associated steatohepatitis.